Case Insight: Natco acquires Dash Pharmaceuticals
Posted on17 Dec 2021
Comments0
NATCO Pharma, through its affiliates, is proposing to enter into an agreement to acquire Dash Pharmaceuticals LLC subject to satisfactory completion of... Read More
Cadila launches ayurvedic energy tonic Healtherbs
Drug major Cadila Pharmaceuticals has introduced an ayurvedic general health tonic that helps keep the body young, active and fit. The key... Read More
Cipla’s social initiative to improve access to nebulisers in primary healthcare centres of rural India
Cipla Limited announced a first-of-its-kind initiative to improve access to nebulization therapy specifically for patients in the rural sections of the country.... Read More
Pharma Case Study: Merck’s $11.5B acquisition of Acceleron
Posted on03 Oct 2021
Comments0
Merck will acquire Acceleron Pharma, Inc. XLRN for $180 per share in cash for an approximate total equity value of $11.5 billion... Read More
Sanofi Bangladesh Limited’s majority stake is acquired by Beximco Pharma, Bangladesh
Beximco Pharmaceuticals Limited, one of leading pharmaceutical company based at Bangladesh, have completed its acquisition of the majority stake (54.6%) in Sanofi... Read More
What are the difference between Wholesaler and Specialty Pharmacy?
Posted on07 Sep 2021
Comments0
There are clear cut difference between the two terms. The wholesalers are the first purchaser of the drug, directly from manufacturer. Specialty... Read More
DRL enters agreement to sell its rights to anti-cancer agent E7777 to Citius Pharma
Dr Reddy’s Laboratories Ltd announced that it has entered into a definitive agreement with Citius Pharmaceuticals, Inc. pursuant to which it sold... Read More
Nucala received USFDA approval to treat chronic rhinosinusitis with nasal polyps
GlaxoSmithKline (GSK) announced that the US Food and Drug Administration (FDA) have approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5),... Read More
FDC launches Favipiravir oral suspension to treat mild to moderate cases of COVID-19
Pharma firm FDC Ltd on Monday said it has launched oral suspension of Favipiravir to treat mild to moderate cases of COVID-19... Read More
Sun Pharma launches a special initiative ‘Sunkalp’ for the welfare of doctors
Posted on16 Jul 2021
Comments0
Sun Pharmaceutical Industries launched a special initiative ‘Sunkalp’ for the welfare of doctors, their families and the community. The company stated that... Read More